LACTOSE (INDIA)
Back to Cashflow Statement
|
LACTOSE (INDIA) Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-0.29 Cr | ₹8.75 Cr | ₹7.89 Cr | ₹8.47 Cr | ₹2.17 Cr |
What is the latest Cash Flow from Operating Activities ratio of LACTOSE (INDIA) ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-0.29 Cr |
| Mar2024 | ₹8.75 Cr |
| Mar2023 | ₹7.89 Cr |
| Mar2022 | ₹8.47 Cr |
| Mar2021 | ₹2.17 Cr |
How is Cash Flow from Operating Activities of LACTOSE (INDIA) Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.29 Cr | Negative | |
| Mar2024 | ₹8.75 Cr | 10.79 | |
| Mar2023 | ₹7.89 Cr | -6.78 | |
| Mar2022 | ₹8.47 Cr | 291.09 | |
| Mar2021 | ₹2.17 Cr | - | |
Compare Cash Flow from Operating Activities of peers of LACTOSE (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LACTOSE (INDIA) | ₹131.0 Cr | -2.8% | 3.2% | -18% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,539.0 Cr | -1.4% | -6.6% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 1.2% | -2.6% | 60% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,251.0 Cr | -2% | -6.1% | 33% | Stock Analytics | |
| CIPLA | ₹105,290.0 Cr | -2.3% | -5.8% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,752.6 Cr | -1.1% | 3.8% | -5.5% | Stock Analytics | |
LACTOSE (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LACTOSE (INDIA) | -2.8% |
3.2% |
-18% |
| SENSEX | 0.8% |
-4.8% |
-10.5% |
You may also like the below Video Courses